Retractable Technologies Inc (RVP) stock
Close on Nov 13, 2026Market cap $16.76MP/E –Yield –
Retractable Technologies Inc saw revenue fall 11.2% to $33.90M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $16.76M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $16.76M
- P/E ratio
- –
- Price to sales
- 0.49
- Price to book
- 0.23
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $33.90M
- Net income
- -$3.37M
- EPS, diluted
- -$0.12
- Book value per share
- $2.43
- Diluted shares
- 30M
Trading
- Previous close
- $0.56
- Open
- $0.56
- Day's range
- $0.55 – $0.56
- Volume
- 17,505
- Average volume (20 days)
- 23,533
- Beta (5 years)
- 0.79
- 52-week range
- $0.55 – $0.87
- RSI (14 days)
- 28.3
- Volatility (1 year)
- 39.4%
- Relative volume
- 0.59×
- WACC
- 9.0%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | RVP | S&P 500 | Difference | RVP per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -8.2% | -3.0% | −5.2 pts | ||
| 3 months | -17.5% | -2.8% | −14.7 pts | ||
| Year to date | -27.5% | +11.5% | −39.0 pts | ||
| 1 year | -30.9% | +13.5% | −44.3 pts | ||
| 3 years | -42.3% | +77.7% | −120.0 pts | -16.7% | +21.1% |
| 5 years | -93.9% | +72.6% | −166.5 pts | -42.8% | +11.5% |
| 10 years | -77.2% | +308.2% | −385.4 pts | -13.8% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Retractable Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
About Retractable Technologies
Surgical & Medical Instruments & Apparatus
Retractable Technologies, Inc. designs, manufactures, and markets safety medical devices for the healthcare industry, with a primary focus on injection equipment. Its principal offerings include retractable syringes and needles sold under brand names such as VanishPoint, Patient Safe, and EasyPoint, which feature safety mechanisms designed to prevent needlestick injuries, inhibit reuse, and reduce medication waste. The company markets its products primarily to healthcare providers through group purchasing organizations, specialty distributors, and a direct marketing network.
Company profile, executives and historyRetractable Technologies stock: common questions
What is Retractable Technologies's stock price?
RVP closed at $0.56 on Nov 13, 2026, up 0.88% on the day. Over the past 52 weeks it traded between $0.55 and $0.87.
What is Retractable Technologies's market cap?
Retractable Technologies was worth $16.76M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is RVP's P/E ratio?
Retractable Technologies lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.12), so it has no meaningful P/E ratio.
How much revenue does Retractable Technologies make?
Retractable Technologies reported revenue of $33.90M for the twelve months to Jun 30, 2026, down 11.2% from a year earlier.
Does Retractable Technologies pay a dividend?
No. Retractable Technologies has not paid a cash dividend over the last twelve months.
How has RVP stock performed over the past year?
Including dividends, RVP returned -30.9% over the past year, against +13.5% for the S&P 500.
How many RVP shares are sold short?
0M shares were sold short at the latest FINRA report, 0.17% of the float, or 1.1 days of average trading volume.
Who are Retractable Technologies's competitors?
Companies most similar to Retractable Technologies by business, industry and size include UTMD, BDMD, MHUAF, KRMD, SNOA.
See a number that looks wrong?